Mefloquine: The benefits outweigh the risks

British Journal of Clinical Pharmacology

Volumn 42, Issue 4, 1996, Pages 411-413

  Winstanley, Peter ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEFLOQUINE;

ANOREXIA; DRUG TOLERANCE; HUMAN; INSOMNIA; MALARIA; MORTALITY; NAUSEA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROPHYLAXIS; RISK BENEFIT ANALYSIS; RISK FACTOR; SHORT SURVEY; SKIN TOXICITY; TERATOGENICITY; VERTIGO;

EID: 0029795230     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1996.tb00002.x     Document Type: Short Survey

References (15)

1. Greenwood D. Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. J Antimicrob Chemother 1995; 36: 857-872.
2. Karbwang J, White NJ. The clinical pharmacokinetics of mefloquine. Clin Pharmacokin 1990; 19: 264-279.
3. Bradley DJ, Warhurst DC. Malaria prophylaxis: guidelines for travellers from Britain. Br Med J 1995; 310: 709-714.
4. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Safety 1996; 14: 131-145.
5. Pirmohamed M, Winstanley PA. Antiprotozoal drugs. In Meyler's Side Effects of Drugs Annual 17, eds. Aronson JK, van Boxtel CJ. Elsevier, 1993: 325-337.
6. Pirmohamed M, Winstanley PA. Antiprotozoal drugs. In Meyler's Side Effects of Drugs Annual 18, eds. Aronson JK, van Boxtel CJ. Elsevier, 1994: 286-299.
7. Ter Kuile F, Nosten F, Luxemberger C et al. Mefloquine treatment of acute falciparum malaria - a prospective study of non-serious adverse effects in 3673 patients. Bull WHO 1995; 73: 631-642.
8. Thompson C. Malaria pill stands accused. New Scientist, 27th April 1996; 14-15.
9. Cook G. Malaria prophylaxis: mefloquine toxicity should limit its use to treatment alone, Br Med J 1995; 311: 190-191 (letter).
10. Davis TME et al. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial. Br J Clin Pharmacol 1996; 42: 415-421.
11. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341: 848-851
12. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 1993; 341: 1299-1303.
13. Boudreau E, Schuster B, Sanchez J, et al. Tolerability of prophylactic Lariam regimens. Trop-Med-Parasitol 1993; 44: 257-265
14. Anon. Notifications of infectious diseases. Communicable Dis Rep 1996; 6: 201-204.
15. Haines P. Media scare prompts 53% rise in malaria. GP News January 26 1996.